Type II variation for application Roszdravnadzor-2021-0079. Type II variation: New Dosage Strength for Brextanib — critical change

Variation Number
Roszdravnadzor-2021-0079-V079
Type
Type II
Status
Draft
Fee
€43,813
Submitted
—
Approved
—
Description

Type II variation: New Dosage Strength for Brextanib — critical change